XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 47.33%553.86M | 47.89%155.76M | 63.01%148.36M | 45.27%131.31M | 32.88%118.54M | 14.93%375.93M | 18.83%105.32M | 12.79%91.01M | 13.48%90.4M | 14.20%89.2M |
Total premiums earned | 47.63%510.69M | 54.55%144.89M | 58.06%135.65M | 47.14%122.29M | 29.58%107.87M | 9.30%345.91M | 14.01%93.75M | 10.10%85.82M | 3.54%83.11M | 9.48%83.24M |
-Net premiums written | 57.27%644.85M | 47.92%169.23M | 44.32%159.71M | 67.32%176M | 75.39%139.91M | 14.76%410.03M | 29.06%114.41M | 21.34%110.66M | 9.50%105.19M | -1.98%79.77M |
-Increase decrease in net unearned premium reserves | -109.26%-134.16M | -17.81%-24.34M | 3.14%-24.06M | -143.29%-53.72M | -1,022.57%-32.04M | -57.04%-64.11M | -221.62%-20.66M | -87.42%-24.85M | -39.77%-22.08M | 164.92%3.47M |
Net investment income | 1,412.20%35.82M | 303.06%11.32M | 288.07%2.7M | -66.20%336K | --3.82M | 141.59%2.37M | 1.81%2.81M | 37.29%-1.43M | 120.91%994K | ---- |
Net realized gain loss on investments | 7,914.04%4.57M | -5,104.17%-1.2M | ---286K | 125.00%18K | -4,924.00%-1.21M | 102.45%57K | 101.18%24K | --0 | 107.34%8K | 1,150.00%25K |
Fee revenue and other income | -17.32%2.78M | -52.71%750K | 53.76%715K | 27.54%792K | -24.03%528K | -21.18%3.37M | 38.76%1.59M | -65.86%465K | -37.27%621K | -10.55%695K |
-Fees and commissions | -17.32%2.78M | -52.71%750K | 53.76%715K | 27.54%792K | -24.03%528K | -21.18%3.37M | 38.76%1.59M | -65.86%465K | -37.27%621K | -10.55%695K |
Interest income | ---- | ---- | 55.52%9.59M | 39.13%7.88M | 43.54%7.52M | 68.55%24.22M | 58.05%7.15M | 59.42%6.16M | 73.43%5.67M | 93.18%5.24M |
Total expenses | 47.88%402.67M | 54.19%110.8M | 65.25%109.85M | 45.36%97.94M | 26.45%84.18M | 4.91%272.28M | 12.90%71.86M | -11.94%66.48M | 9.79%67.38M | 12.79%66.57M |
Loss adjustment expense | 85.64%134.76M | 107.73%37.18M | 149.80%40.32M | 69.96%30.43M | 29.95%26.84M | -7.73%72.59M | -2.85%17.9M | -47.77%16.14M | 24.36%17.91M | 38.10%20.65M |
Policy acquisition expense | 38.90%149.66M | 39.92%40.59M | 53.57%41.47M | 37.41%35.81M | 23.83%31.8M | -2.73%107.75M | 8.05%29.01M | -0.76%27M | -9.09%26.06M | -8.47%25.68M |
Underwriting expenses | 32.82%117.11M | 36.09%32.95M | 25.63%28.13M | 39.74%31.23M | 29.04%24.8M | 27.38%88.17M | 34.60%24.21M | 30.83%22.39M | 22.84%22.35M | 20.70%19.22M |
Non-operating net interest income (expenses) | 69.85%-1.14M | 89.43%-87K | 89.97%-87K | 78.85%-225K | 27.45%-740K | -332.42%-3.78M | -106.78%-823K | -221.11%-867K | -858.56%-1.06M | -996.77%-1.02M |
-Interest expense-non operating | -69.85%1.14M | -89.43%87K | -89.97%87K | -78.85%225K | -27.45%740K | 332.42%3.78M | 106.78%823K | 221.11%867K | 858.56%1.06M | 996.77%1.02M |
Income from associates and other participating interests | ---- | ---- | 292.21%148K | ---245K | ---- | ---- | ---- | ---77K | --0 | ---- |
Income before tax | 45.88%151.2M | 34.38%44.96M | 56.93%38.5M | 44.98%33.37M | 51.82%34.36M | 53.43%103.64M | 33.96%33.46M | 372.01%24.54M | 25.84%23.02M | 18.58%22.63M |
Income tax | 37.57%33.62M | 32.17%10M | 31.18%8.01M | 40.07%7.65M | 50.00%7.97M | 58.90%24.44M | 21.65%7.56M | 569.19%6.1M | 47.35%5.46M | 16.91%5.32M |
Earnings from equity interest net of tax | ||||||||||
Net income | 48.45%117.57M | 35.02%34.97M | 65.46%30.5M | 46.50%25.73M | 52.38%26.38M | 51.81%79.2M | 38.05%25.9M | 330.05%18.43M | 20.38%17.56M | 19.10%17.31M |
Net Income continuous operations | 48.45%117.57M | 35.02%34.97M | 65.46%30.5M | 46.50%25.73M | 52.38%26.38M | 51.81%79.2M | 38.05%25.9M | 330.05%18.43M | 20.38%17.56M | 19.10%17.31M |
Minority interest income | ||||||||||
Net income attributable to the parent company | 48.45%117.57M | 35.02%34.97M | 65.46%30.5M | 46.50%25.73M | 52.38%26.38M | 51.81%79.2M | 38.05%25.9M | 330.05%18.43M | 20.38%17.56M | 19.10%17.31M |
Preferred stock dividends | ||||||||||
Other preferred stock dividend | ||||||||||
Net income attributable to common stockholders | 48.45%117.57M | 35.02%34.97M | 65.46%30.5M | 46.50%25.73M | 52.38%26.38M | 51.81%79.2M | 38.05%25.9M | 330.05%18.43M | 20.38%17.56M | 19.10%17.31M |
Basic earnings per share | 44.51%4.61 | 25.71%1.32 | 57.33%1.18 | 45.07%1.03 | 53.62%1.06 | 54.11%3.19 | 41.89%1.05 | 341.18%0.75 | 22.41%0.71 | 21.05%0.69 |
Diluted earnings per share | 43.13%4.48 | 26.47%1.29 | 57.53%1.15 | 44.93%1 | 52.94%1.04 | 54.95%3.13 | 39.73%1.02 | 329.41%0.73 | 21.05%0.69 | 21.43%0.68 |
Dividend per share | ||||||||||
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |